- Artificial cells, blood substitutes, and immobilization biotechnology
-
影響因子:
0.854
-
I S S N:
1073-1199
-
出 版 社:
Informa Healthcare
-
出 版 地:
London
-
出版國(guó)家:
England
-
刊 期:
雙月刊
-
創(chuàng)刊時(shí)間:
1994
-
語(yǔ) 種:
英文
-
審稿周期:
較慢,6-12周
-
中科院分區(qū):
4
-
投稿命中率:
容易
-
國(guó)外數(shù)據(jù)庫(kù)收錄:
IM
-
中國(guó)收錄文章數(shù):
89
-
5年影響因子:
0.826
-
研究領(lǐng)域:
生物材料、生物制劑、生物技術(shù)、血液代用品
-
官方鏈接:
http://informahealthcare.com/loi/abb
-
投稿須知:
http://informahealthcare.com/loi/abb
期刊介紹:
This journal covers artificial cells, blood substitutes, and immobilization biotechnology including gene therapy, cell therapy, enzyme therapy, bioencapsulation, microencapsulation, nanocapsules, nanoparticles, artificial organs, biomaterials, hybrid artificial organs, drug delivery systems, hemoperfusion, sorbents, immunosorbents, and biotechnology. The emphasis is on interdisciplinary interactions from basic and applied research to clinical trials. For a complete listing of topics covered, see the Instructions to Authors at the end of this issue.